Simulations Plus Subsidiary DILIsym Awarded Grant for up to $1.7 Million For Model Development

DILIsym Services, Inc., a Simulations Plus company developing in silico modeling software, resources, and information for assisting the pharmaceutical industry to more efficiently develop safe and effective drug therapies, today announced it has been awarded a Fast-Track Small Business Innovation Research (SBIR) grant by the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK).

Please to read the entire article.